Stimcell Energetics Financials

STME

Source SEC Filings (10-K/10-Q) Data as of Feb 28, 2026 Currency USD FYE May

This page shows Stimcell Energetics (STME) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI STME FY2025 2026-04-27

STME now looks like a balance-sheet workout more than an operating business, with liabilities dwarfing assets.

Liquidity kept eroding even through a temporary liability reset: cash fell from $98K in FY2023 to $43K in FY2024 and $15K in FY2025, while liabilities dropped from $2.5M to $873K before rising again to $1.3M. That pattern suggests the balance sheet was not stabilizing so much as being periodically reworked while cash resources kept shrinking.

By FY2025, interest burden of $38K was larger than year-end cash on hand of $15K, and assets were only $21K against $1.3M of liabilities. That combination means financing obligations, not operating scale, are the clearest force shaping the company’s reported position.

Some figures from recent filings were inconsistent and were omitted from this summary.

Financial Health Signals

Financial health score pending refresh

We are recalculating Stimcell Energetics's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$15K

YoY-66.4%

5Y CAGR-20.2%

10Y CAGR+27.8%

Stimcell Energetics held $15K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

STME Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	$0-100.0%	$3K-54.5%	$6K-10.3%	$7K-92.9%	$96K
Cost of Revenue	N/A	N/A	N/A	$2K-37.3%	$3K-68.3%	$10K
Gross Profit	N/A	$0-100.0%	$483-88.0%	$4K+14.5%	$4K-95.9%	$86K
R&D Expenses	N/A	N/A	$89K-40.8%	$151K-34.4%	$230K-41.6%	$393K
SG&A Expenses	N/A	$116K-57.8%	$276K	N/A	$186K-53.1%	$396K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$38K-37.9%	$62K+30.1%	$47K+84.5%	$26K-19.8%	$32K+52.0%	$21K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	-$142K+71.2%	-$495K	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$8K-95.0%	$164K	N/A	N/A	$33K+44.8%	$23K+37.9%	$16K	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$19K+11.7%	$17K+26.1%	$13K	N/A	$9K+7.3%	$9K-0.5%	$9K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$91K	N/A	N/A	N/A	N/A	-$140K-108.5%	-$67K	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

STME Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$21K-54.0%	$46K-55.3%	$103K+149.8%	$41K-20.9%	$52K-67.2%	$159K
Current Assets	N/A	N/A	N/A	$41K-19.0%	$51K-67.6%	$157K
Cash & Equivalents	$15K-66.4%	$43K-55.8%	$98K+303.2%	$24K+17.5%	$21K-54.0%	$45K
Inventory	N/A	N/A	N/A	N/A	$0-100.0%	$52K
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.3M+45.3%	$873K-64.9%	$2.5M+21.4%	$2.1M+25.9%	$1.6M-3.0%	$1.7M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.2M-50.8%	-$826K+65.4%	-$2.4M-18.7%	-$2.0M-27.5%	-$1.6M-3.7%	-$1.5M
Retained Earnings	-$10.9M-5.5%	-$10.3M-1.4%	-$10.2M-5.1%	-$9.7M-7.8%	-$9.0M-11.3%	-$8.0M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$35K-34.1%	$52K+219.4%	$16K-22.8%	$21K+24.0%	$17K-55.4%	$38K+71.2%	$22K-51.4%	$46K
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$10K-77.8%	$46K+617.1%	$6K-55.9%	$15K+118.3%	$7K-80.3%	$34K+64.6%	$21K-52.7%	$43K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$1.7M+7.4%	$1.6M+13.1%	$1.4M+11.3%	$1.3M+16.6%	$1.1M+6.5%	$1.0M+9.7%	$931K+6.7%	$873K
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$1.7M-8.8%	-$1.5M-10.6%	-$1.4M-11.8%	-$1.2M-16.5%	-$1.1M-8.9%	-$983K-8.1%	-$909K-10.0%	-$826K
Retained Earnings	-$11.5M-0.8%	-$11.4M-2.8%	-$11.1M-2.4%	-$10.9M-2.1%	-$10.6M-1.3%	-$10.5M-1.3%	-$10.4M-0.6%	-$10.3M

STME Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	-$146K+46.4%	-$272K	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	$0-100.0%	$2K-36.1%	$2K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	$0+100.0%	-$2K+36.1%	-$2K
Financing Cash Flow	N/A	$91K-73.7%	$346K	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	-$86K-16.4%	-$74K	N/A	-$58K-33.7%	-$44K-164.6%	-$17K+27.9%	-$23K+29.0%	-$32K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$50K-56.2%	$114K	N/A	$66K+294.8%	$17K-44.2%	$30K	$0+100.0%	-$4K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

STME Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	17.5%-49.0pp	66.5%+14.4pp	52.1%-37.2pp	89.3%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	-17923.3%	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-308.9%+170.4pp	-479.4%	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	-1.02+0.0	-1.06-0.0	-1.04-0.0	-1.02+0.0	-1.03+0.1	-1.10
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-262.4%	N/A	N/A	N/A	N/A	-363.8%-65.0pp	-298.8%	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	-1.02+0.0	-1.03-0.0	-1.010.0	-1.020.0	-1.02+0.0	-1.04-0.0	-1.02+0.0	-1.06
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$1.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Remsleep Holding RMSL

$4.2M

Bioelectronics Corp BIEL

$4.9M

Adm Tronics ADMT

$2.7M

Odyssey Health Inc ODYY

$707K

NUGEN MEDICAL DEVICES INC NGMDF

$3.6M

Frequently Asked Questions

What are Stimcell Energetics's total assets?

Stimcell Energetics (STME) had $21K in total assets as of fiscal year 2025, including both current and long-term assets.

What is Stimcell Energetics's debt-to-equity ratio?

Stimcell Energetics (STME) had a debt-to-equity ratio of -1.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Stimcell Energetics's debt-to-equity ratio negative or unusual?

Stimcell Energetics (STME) has negative shareholder equity of -$1.2M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.